How Much Does Rapamycin (Sirolimus) Cost in North Carolina in 2026?

Retail Pricing Breakdown for Sirolimus in North Carolina

The sticker price for brand-name Rapamune (sirolimus) from Pfizer sits near $600 per month for transplant-dose regimens, according to the drug's FDA-approved labeling and pricing data 1. Generic sirolimus tablets, manufactured by companies including Greenstone and Biocon, have reduced cash-pay costs substantially since the original patent expired.

Generic vs. Brand Pricing

Across North Carolina retail pharmacies in 2026, the average cash-pay price for generic sirolimus is approximately $80 per month. That figure reflects 30 tablets of 1 mg sirolimus at independent and chain pharmacies statewide. The brand-name Rapamune product remains on the market at roughly 7.5 times the generic price. Pharmacists may substitute generics automatically under North Carolina General Statute § 90-85.28 unless the prescriber writes "dispense as written" 2.

Why Prices Vary Between Pharmacies

Pricing differences of 30% to 50% between pharmacies in the same city are common for generic sirolimus. Independent pharmacies sometimes offer lower cash prices than large chains because they negotiate directly with wholesalers. Costco and warehouse pharmacies in Charlotte, Raleigh, and Greensboro frequently post below-average prices even for non-members. The FDA's Orange Book confirms therapeutic equivalence ratings for approved generic sirolimus products, meaning bioequivalence has been demonstrated in pharmacokinetic studies 3.

Compounded Sirolimus: Cost and Legality in North Carolina

Compounded sirolimus is legal in North Carolina when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. The FDA distinguishes between 503A (patient-specific) and 503B (outsourcing facility) compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act 4.

What 503A Compounding Costs

Compounded sirolimus typically costs around $120 per month in North Carolina. That premium over generic tablets reflects the labor-intensive process of custom formulation, often into capsules or topical preparations. Some longevity-focused clinicians prefer compounded formulations because they allow precise low-dose adjustments (e.g., 1 mg, 3 mg, or 5 mg capsules for weekly protocols).

Choosing a Compounding Pharmacy

Not every compounding pharmacy in North Carolina stocks sirolimus. The drug requires cold-chain handling and specialized quality controls. The North Carolina Board of Pharmacy oversees 503A compounding standards, and patients should verify that any compounding pharmacy holds current NCBOP licensure. The Pharmacy Compounding Accreditation Board (PCAB) offers voluntary accreditation that signals higher quality standards 5.

Insurance Coverage for Sirolimus in North Carolina

Private insurance coverage for sirolimus in North Carolina depends heavily on the indication. For FDA-approved uses, including prevention of organ rejection after renal transplantation and treatment of lymphangioleiomyomatosis (LAM), most commercial plans cover sirolimus with a specialty-tier copay 6.

Transplant and LAM Coverage

The FDA approved sirolimus for renal transplant rejection prophylaxis in 1999 and for LAM in 2015 7. The LAM approval was based on the MILES trial (N=89), which demonstrated a stabilization of FEV1 decline and reduction in serum VEGF-D levels. For these on-label indications, Blue Cross Blue Shield of North Carolina, Aetna, and UnitedHealthcare plans typically cover sirolimus on formulary, though prior authorization may be required.

Off-Label Longevity Use

Off-label prescribing of sirolimus for aging or longevity is not covered by any major North Carolina insurer as of 2026. Patients using sirolimus in weekly low-dose protocols for its mTOR-inhibiting, geroprotective properties will pay cash. The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity), published in Aging Cell in 2024, provided early human safety data for low-dose rapamycin in healthy older adults, but no insurer has adopted coverage based on these results 8.

North Carolina Medicaid and Sirolimus

North Carolina Medicaid does not cover sirolimus for off-label longevity indications. Coverage is limited to FDA-approved transplant and LAM indications with appropriate prior authorization documentation. North Carolina completed its Medicaid managed care transition in 2024, and formulary decisions now flow through contracted health plans including WellCare, Healthy Blue, AmeriHealth Caritas, and UnitedHealthcare Community Plan 9.

Transplant Patients on Medicaid

For Medicaid-enrolled transplant recipients, sirolimus is typically covered under the pharmacy benefit with a nominal copay of $1 to $3 per prescription. Medicaid drug rebate agreements between CMS and generic manufacturers keep net costs low for state programs 10. Transplant patients should confirm formulary status with their specific managed care plan, as preferred drug lists may vary.

No Pathway for Off-Label Coverage

North Carolina Medicaid does not recognize anti-aging or geroprotective use as a covered indication. There is no compendia listing for sirolimus in longevity applications. The American Geriatrics Society has not issued guidelines endorsing mTOR inhibitors for aging, and without a recognized compendia or guideline basis, Medicaid prior authorization appeals for off-label longevity use will be denied 11.

Discount Programs and Savings Strategies

Several approaches can reduce out-of-pocket sirolimus costs for North Carolina residents paying cash.

Manufacturer and Generic Savings Cards

Pfizer offers a savings card for brand-name Rapamune that can reduce copays for commercially insured patients. Generic manufacturers including Greenstone have periodically offered discount programs. These cards typically cannot be used with Medicare or Medicaid. The NeedyMeds database tracks current patient assistance programs for sirolimus 12.

Pharmacy Discount Programs

GoodRx, RxSaver, and similar aggregators often show generic sirolimus prices between $50 and $110 at North Carolina pharmacies. Warehouse clubs and mail-order pharmacies tend to offer the lowest per-unit pricing. Mark Cuban's Cost Plus Drugs has also listed generic sirolimus at near-wholesale margins.

Pill Splitting (With Caution)

Some patients prescribed low weekly doses purchase 2 mg tablets and split them to achieve a 1 mg dose, effectively halving the per-dose cost. Sirolimus tablets are scored, and the FDA label permits splitting at the score line 13. Patients should only split tablets with physician guidance, and splitting is not appropriate for compounded capsules or solution formulations.

Telehealth Access to Sirolimus in North Carolina

Telehealth prescribing of sirolimus is legal in North Carolina. The state enacted permanent telehealth flexibilities following the COVID-19 public health emergency, and the North Carolina Medical Board permits prescribing via audio-visual telehealth encounters for established and new patients when clinically appropriate.

How Telehealth Longevity Clinics Work

A growing number of telehealth platforms now offer sirolimus prescriptions for off-label longevity use after physician consultation, lab review, and informed consent. These clinics typically require baseline labs including a complete metabolic panel, fasting lipid panel, fasting glucose, and CBC. The Interventions Testing Program (ITP) at the National Institute on Aging first demonstrated rapamycin's lifespan extension in mice in 2009, and this finding catalyzed clinical interest in human applications 14.

Lab Monitoring Requirements

Ongoing monitoring for patients on sirolimus, even at low doses, should include lipid panels every 3 to 6 months. Rapamycin can increase LDL cholesterol and triglycerides through mTORC1 inhibition of lipid metabolism pathways 15. A 2015 meta-analysis in Transplantation found that sirolimus-treated transplant patients had a 40% higher incidence of hyperlipidemia compared to calcineurin inhibitor-treated controls. For low-dose weekly protocols, lipid changes tend to be milder, but monitoring remains standard practice.

How Rapamycin Works: The mTOR Connection

Sirolimus inhibits the mechanistic target of rapamycin (mTOR), a serine/threonine kinase that regulates cell growth, proliferation, and autophagy. The mTOR pathway integrates signals from nutrients, growth factors, and energy status to control protein synthesis and cellular metabolism 16.

mTORC1 vs. MTORC2

MTOR operates in two distinct complexes. MTORC1, the primary target of rapamycin, drives anabolic processes including protein translation via S6K1 and 4E-BP1 phosphorylation. Intermittent low-dose rapamycin preferentially inhibits mTORC1 while sparing mTORC2, which is involved in insulin signaling and glucose metabolism. This selectivity is the pharmacologic rationale behind weekly dosing protocols for longevity applications 17.

Evidence in Human Aging

The PEARL trial enrolled 150 healthy adults aged 50 to 85 and randomized them to rapamycin 5 mg weekly or placebo for 12 months. The study's primary endpoint was safety, and the trial reported no serious adverse events attributable to rapamycin 8. Secondary endpoints showed trends toward improved immune function, as measured by response to influenza vaccination, consistent with an earlier trial by Mannick et al. That demonstrated enhanced immune response in older adults given the rapalog everolimus 18.

Side Effects and Safety at Low Doses

The most commonly reported side effects of sirolimus at transplant doses (2 to 5 mg daily) include mouth ulcers, hyperlipidemia, thrombocytopenia, and impaired wound healing, per the FDA prescribing information 1.

Low-Dose Weekly Protocols

At the 1 to 6 mg once-weekly doses used off-label for longevity, side effects appear less frequent and less severe. The PEARL trial reported oral ulcers in 8% of the rapamycin group versus 3% of placebo, with no cases requiring treatment discontinuation 8. Lipid elevations were modest: mean LDL increased by 12 mg/dL in the treatment group, a clinically manageable change for most patients.

Who Should Not Take Rapamycin

Sirolimus is contraindicated in patients with known hypersensitivity to the drug or its excipients. Patients who are immunosuppressed for reasons other than transplant (e.g., active chemotherapy, uncontrolled HIV) should not use rapamycin. Pregnant or breastfeeding women should avoid sirolimus, as animal studies have shown embryo-fetal toxicity 19. Patients with hepatic impairment require dose adjustment because sirolimus is extensively metabolized by CYP3A4 and P-glycoprotein.

North Carolina Pharmacy Options at a Glance

| Source | Approximate Monthly Cost | Notes | |---|---|---| | Brand Rapamune (Pfizer) | $600 | List price before insurance | | Generic sirolimus (retail) | $80 | NC average cash price, 2026 | | Compounded sirolimus (503A) | $120 | Custom capsules, requires Rx | | Discount platform (GoodRx, etc.) | $50 to $110 | Varies by pharmacy and quantity | | Mail-order pharmacy | $60 to $90 | 90-day supply often cheaper |